Développement de méthodes analytiques pour la protéomique et l'identification de peptides MHC I issus de cellules leucémiques

Développement de méthodes analytiques pour la protéomique et l'identification de peptides MHC I issus de cellules leucémiques

Show other versions (1)

Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal.

Bibliographic Details
Main Author:	Fortier, Marie-Hélène
Other Authors:	Thibault, Pierre
Language:	en
Published:	2012
Subjects:	Peptides MHC I MHC I peptides Spectrométrie de masse Mass spectrometry Profil d'expression Expression profiling Microfluidique Microfluidic Chromatographie liquide capillaire Capillary liquid chromatography Leucémie Leukemia Transcriptome Immunothérapie Immunotherapy Rapamycine Rapamycin Voie de signalisation mTOR mTOR signaling pathway
Online Access:	http://hdl.handle.net/1866/6563

Similar Items

Développement de méthodes analytiques pour la protéomique et l'identification de peptides MHC I issus de cellules leucémiques
by: Fortier, Marie-Hélène
Published: (2012)

INHIBITION OF mTOR KINASE AFFECTS ASTROCYTES GFAP mRNA EXPRESSION IN IN VITRO CONDITIONS
by: Anna Latacz, et al.
Published: (2014-02-01)

mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)

Rapamycin Inhibits Expansion of Cord Blood Derived NK and T Cell
by: Monireh Zare, et al.
Published: (2017-09-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Genetics of tuberous sclerosis complex: implications for clinical practice
by: Caban C, et al.
Published: (2016-12-01)

The role of mammalian target of rapamycin (mTOR) in macrophage polarization
by: Byles, Vanessa A.
Published: (2016)

Paradigmenwechsel in der Anti-Aging-Medizin: Hormesis, Target-of-Rapamycin-Komplex und erste Anti-Aging-Pillen // Paradigm Shift in Anti-Aging Medicine: Hormesis, Target of Rapamycin Complex and First Human Anti-Aging-Pills
by: Römmler A
Published: (2016-01-01)

Dose-dependent Effects of mTOR Inhibition on Weight and Mitochondrial Disease in Mice
by: Simon C Johnson, et al.
Published: (2015-07-01)

Metformin induces degradation of mTOR protein in breast cancer cells
by: Mohamed Alalem, et al.
Published: (2016-11-01)

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells
by: Delphine Séhédic, et al.
Published: (2021-02-01)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01)

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
by: Wang Cun, et al.
Published: (2012-05-01)

Combined Treatment with Doxorubicin and Rapamycin Is Effective against In Vitro and In Vivo Models of Human Glioblastoma
by: Anna Lisa Iorio, et al.
Published: (2019-03-01)

Inhibition of mTOR prevents ROS production initiated by ethidium bromide-induced mitochondrial DNA depletion.
by: Timothy eNacarelli, et al.
Published: (2014-07-01)

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway
by: Lei Liu, et al.
Published: (2018-10-01)

Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats
by: Dai QD, et al.
Published: (2018-12-01)

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
by: Cabrera-López Cristina, et al.
Published: (2012-11-01)

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
by: Daniel J. Beard, et al.
Published: (2021-09-01)

Rapamisinin Sıçanlarda Penisilinle Oluşturulmuş Epileptiform Aktivite Üzerine Etkisi: Bir Elektrofizyolojik Çalışma
by: Seyit Ankaralı, et al.
Published: (2016-09-01)

Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
by: Lan eYe, et al.
Published: (2012-09-01)

PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
by: Carmen Mecca, et al.
Published: (2018-04-01)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
by: Henry Querfurth, et al.
Published: (2021-07-01)

A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea
by: Zhili Deng, et al.
Published: (2021-05-01)

Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
by: Zaixin Guo, et al.
Published: (2021-05-01)

Regulating T Cell Population Alleviates SLE by Inhibiting mTORC1/C2 in MRL/lpr Mice
by: Dongya Zhang, et al.
Published: (2021-01-01)

Autophagy Stimulus-Dependent Role of the Small GTPase Ras2 in Peroxisome Degradation
by: Fahd Boutouja, et al.
Published: (2020-11-01)

Polycystin-2 Is Required for Starvation- and Rapamycin-Induced Atrophy in Myotubes
by: Catalina Kretschmar, et al.
Published: (2019-05-01)

Dysregulation of the mTOR signaling pathway in the pathogenesis of autism spectrum disorders
by: Bożena Gabryel, et al.
Published: (2014-04-01)

Role for Target of Rapamycin (mTOR) Signal Pathway in Regulating Neuronal Injury after Intracerebral Hemorrhage
by: Jie-Ping Wang, et al.
Published: (2017-01-01)

Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
by: Stefano Thellung, et al.
Published: (2019-02-01)

Redesigning TOR Kinase to Explore the Structural Basis for TORC1 and TORC2 Assembly
by: Andrew Hill, et al.
Published: (2018-06-01)

Targeting the master regulator mTOR: a new approach to prevent the neurological of consequences of parasitic infections?
by: Sheila Donnelly, et al.
Published: (2017-11-01)

Dysregulation of the mTOR signaling pathway in the pathogenesis of autism spectrum disorders
by: Bożena Gabryel, et al.
Published: (2014-04-01)

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
by: Jing eJiang, et al.
Published: (2013-08-01)

mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
by: Larisa Ryskalin, et al.
Published: (2018-07-01)

Disrupting Reconsolidation by Systemic Inhibition of mTOR Kinase via Rapamycin Reduces Cocaine-Seeking Behavior
by: Fushen Zhang, et al.
Published: (2021-04-01)

A pulse rapamycin therapy for infantile spasms and associated cognitive decline
by: Emmanuel Raffo, et al.
Published: (2011-08-01)

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
by: Alexandre el Hage, et al.
Published: (2021-03-01)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Belinda Seto
Published: (2012-12-01)

Cannot write session to /tmp/vufind_sessions/sess_j3jjvvfc1bl36gijdris992f84